ONTOLOGY REPORT - ANNOTATIONS
Term: oxytetracycline
Accession: CHEBI:27701
browse the term
Definition: A tetracycline used for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae (respiratory infections), and Diplococcus pneumoniae.
Synonyms: exact_synonym: (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
related_synonym: 5-Hydroxytetracycline; C22H24N2O9; InChI=1S/C22H24N2O9/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29/h4-6,12-14,17,25,27-29,32-33H,1-3H3,(H2,23,31)/t12-,13-,14+,17+,21-,22+/m1/s1; InChIKey=IWVCMVBTMGNXQD-PXOLEDIWSA-N; Oxyterracin; Oxyterracine; Oxytetracyclin; Oxytetracycline (anhydrous); Oxytetracycline amphoteric; [H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)c4c(O)cccc4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C; oxitetraciclina; oxytetracyclinum
alt_id: CHEBI:25811; CHEBI:521157; CHEBI:596903; CHEBI:7871
xref_casrn: 79-57-2
xref: Beilstein:2686362 "Beilstein Registry Number"; Beilstein:2714587 "Beilstein Registry Number"; ChEBI:LMPK07000005 "LIPID MAPS instance"; ChEMBL:17638695 "PubMed citation"; ChEMBL:17870541 "PubMed citation"; ChEMBL:521157 "ChEMBL COMPOUND"; ChEMBL:596903 "ChEMBL COMPOUND"; ChemIDplus:79-57-2 "CAS Registry Number"; CiteXplore:1650428 "PubMed citation"; DrugBank:DB00595 "DrugBank"; Gmelin:623487 "Gmelin Registry Number"; KEGG COMPOUND:79-57-2 "CAS Registry Number"; KEGG COMPOUND:C06624 "KEGG COMPOUND"
xref_mesh: MESH:D010118
xref: Reaxys:2714587 "Reaxys Registry Number"; Wikipedia:Oxytetracycline "Wikipedia"
oxytetracycline
G
CCL2
chemokine (C-C motif) ligand 2
decreases expression
EXP
17
32,582,296
32,584,222
RGD:6480464
CTD
G
CCL3
chemokine (C-C motif) ligand 3
decreases expression
EXP
17
34,415,602
34,417,506
RGD:6480464
CTD
G
CCL4
chemokine (C-C motif) ligand 4
decreases expression
EXP
17
34,431,220
34,433,014
RGD:6480464
CTD
G
CCL5
chemokine (C-C motif) ligand 5
decreases expression
EXP
17
34,198,495
34,207,377
RGD:6480464
CTD
G
IL6R
interleukin 6 receptor
decreases expression
EXP
1
154,377,669
154,441,926
RGD:6480464
CTD
G
IL8
interleukin 8
decreases expression
EXP
4
74,606,223
74,609,433
RGD:6480464
CTD
G
SLC22A6
solute carrier family 22 (organic anion transporter), member 6
multiple interactions
EXP
11
62,744,069
62,752,495
RGD:6480464
CTD
G
SLC22A7
solute carrier family 22 (organic anion transporter), member 7
multiple interactions
EXP
6
43,265,998
43,273,276
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
decreases expression
EXP
6
43,737,946
43,754,224
RGD:6480464
CTD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest